Veterinary Infectious Disease Diagnostics Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026

Veterinary Infectious Disease Diagnostics Market is estimated to value over USD 2.8 billion by 2026 end and register a CAGR of over 8% during the forecast period 2019 to 2026.

The report initiates from the outline of business surroundings and explains the commercial summary of chain structure. Moreover, it analyses forecast by technology , by animal type, by infection type , by end user, by region and Veterinary Infectious Disease Diagnostics Market Analysis.

Additionally, this report illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This report provides valuable insights on the general market profit through a profit graph, an in depth SWOT analysis of the market trends along side the regional proliferation of this business vertical.

Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=2313&page=requestsample

Market Segmentation:

This Market is divided By Technology , By Animal type,  By Infection type , By End user, By Region. Regionally, the worldwide Veterinary Infectious Disease Diagnostics Market is fragmented as North America, Europe, Asia Pacific and also the rest of the world.

Key Market Players:

Major market players enclosed within this market are  Agrolabo S.p.A, Demeditec Diagnostics GmbH, Genesig, InBios International, Inc., DRG Diagnostics GmbH, URIT Medical Electronic Group Co., QIAGEN N.V, IDEXX Laboratories, Thermo Fisher Scientific, Virbac, Zoetis, Inc., Randox Laboratories LTD, Creative Diagnostics and IDVet. (Note: The list of the key players are going to be updated with the most recent market scenario and trends)

Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=2313&page=askfordiscount

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points touching market growth

Competitive Landscape:

• Tier 1 players- well-established companies in the market accounting a major market share  
• Tier 2 players 
• Rapidly growing players
• New Entrants

Objectives of the Study:

• To offer with an complete analysis on the Veterinary Infectious Disease Diagnostics Market by technology , by animal type, by infection type , by end user, by region.
• To cater comprehensive data on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To measure and forecast micro-markets and also the overall market
• To predict the market size, in key regions — North America, Europe, Asia Pacific and rest of the world
• To record and evaluate the competitive landscape mapping - product launches, technological advancements, mergers and expansions

Browse Corresponding Healthcare Research Reports& Consulting

• Heart Failure Therapeutics Market is forecasted to value over USD xxx billion by 2026 end and register a CAGR of xx% from the forecast period 2019-2026.
  FutureWise Market Research has illustrated a report on the Heart Failure Therapeutics Market. The report provides an in-depth anatomy of Heart Failure Therapeutics Market trends affecting its growth.
• Congestive Heart Failure Drugs Market is forecasted to value over USD xxx billion by 2026 end and register a CAGR of xx% from the forecast period 2019-2026.
  FutureWise Market Research has illustrated a report on the Congestive Heart Failure Drugs Market. The report provides an in-depth anatomy of Congestive Heart Failure Drugs Market trends affecting its growth.

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

About FutureWise Research:

We specialize in high-growth niche market research, assuring flexibility, agility and customized solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

Company Name: FutureWise Research

Contact Person:  VinayThaploo

Email: sales@futurewiseresearch.com

Phone: +44 141 628 9353 / +1 347 709 4931

City:  Leeds

Country:  United Kingdom

Website: www.futurewiseresearch.com

The global veterinary infectious disease diagnostics market is projected to reach USD 2.2 billion by 2024 from USD 1.4 billion in 2019, at a CAGR of 8.4%. The growth of this market is driven by the growing advancements in diagnostic devices, growth in the companion animal population, rising demand for pet insurance, growth in the number of veterinary practitioners in developed economies, and increasing disease control & disease prevention measures.

Some of the prominent players in the veterinary infectious disease diagnostics market include IDEXX Laboratories, Inc. (US), Zoetis, Inc. (US), QIAGEN N.V. (Indical GmbH) (Germany), Thermo Fisher Scientific, Inc. (US), Neogen Corporation (US), Virbac (France), bioMérieux SA (France), IDVet (France), Randox Laboratories, Ltd. (UK), and Heska Corporation (US).

Get Crucial Industry Insights | Download PDF Brochure Now:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=221816584

Analysis of the developments in the veterinary infectious disease diagnostics market between 2016 and 2019 shows that product launches, market expansions, agreements, partnerships, collaborations, and acquisitions were the most widely adopted growth strategies by players in the market to strengthen their positions.

Idexx Laboratories, Inc. (US) dominated the veterinary infectious disease diagnostics market in 2018. The company offers a broad range of products integral to the market, which are used widely in key regions such as North America, Europe, Asia Pacific, Africa, and the Middle East. Idexx mainly focuses on the development of innovative products to further strengthen its position in the veterinary infectious disease diagnostics market. Some key offerings of the company include SNAP Pro analyzers, SNAP test kits, ELISA kits, SediVue Urine Analyzer, among other products.

Zoetis, Inc. (US) led at the second position in the veterinary infectious disease diagnostics market in 2018. The company has a prominent presence in major markets, such as the US, Brazil, China, and Canada. To strengthen its current position and gain a larger share of the veterinary infectious disease diagnostics market, the company focuses on enhancing the breadth of its product offering. The company also focuses on partnerships and expansions. For example, the company set up a manufacturing facility in China and is also developing infrastructure in Ethiopia, Uganda, and Nigeria.

Get Complete Analysis of Global Market:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=221816584

The veterinary infectious disease diagnostics market is projected to reach USD 2.2 billion by 2024 from USD 1.4 billon in 2019, at a CAGR of 8.4%. The growth of this market is driven by growing advancements in diagnostic devices, growth in the companion animal population, rising demand for pet insurance, growth in the number of veterinary practitioners in developed economies, and increasing disease control & disease prevention measures.

In this report, the global veterinary infectious disease diagnostics market has been segmented into technology, animal type, end-user, and region.  Based on technology, the veterinary infectious disease diagnostics market is segmented into immunodiagnostics, molecular diagnostics, and other veterinary diagnostic technologies. The immunodiagnostics segment is classified further into lateral flow assays, ELISA tests, and other immunodiagnostic products. The molecular diagnostics segment is divided further into PCR tests, microarrays, and other molecular diagnostics products.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=221816584

The immunodiagnostics segment is expected to register the highest growth rate in the veterinary infectious disease diagnostics market during the forecast period. The higher preference for advanced infectious disease diagnostic products by veterinarians, animal farm owners, government institutions & organizations, pet owners, and laboratory technicians; growing demand for early & accurate diagnosis; increasing preference for in-house testing; and the increasing applications of immunodiagnostics are supporting the growth of this application segment.

Based on animal type, veterinary infectious disease diagnostics market is segmented into companion animals and food-producing animals. The animal segment is sub-segmented into viral, bacterial, parasitic, and other infections. In 2018, the companion animals segment accounted for the larger share of the veterinary infectious disease diagnostics market. Increasing pet ownership (especially in developed countries), growing penetration of pet insurance, rising number of veterinary practitioners globally, and the increasing animal disease control and disease prevention measures will continue driving the growth of this segment.

Based on end-user, the veterinary infectious disease diagnostics market is segmented into reference laboratories, veterinary hospitals & clinics, research institutes & universities, and point-of-care/in-house testing. The reference laboratories segment was the largest end-user of the veterinary infectious disease diagnostics market in 2018. The large share of this end-user segment is mainly due to a large number of samples received for analysis in reference laboratories from small and large animal practices

Request Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=221816584

 On the basis of region, the market is segmented into North America (US and Canada), Europe (Germany, UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa. North America accounted for the largest share of the veterinary infectious disease diagnostics market in 2018. Factors such as the increasing demand for prevention, early diagnosis & treatment of veterinary infectious disease diagnostics, growing pet insurance industry, rising veterinary healthcare expenditure, growing awareness of zoonotic diseases, and the growing number of veterinary practices are expected to drive the veterinary infectious disease diagnostics market in the region.

The veterinary infectious disease diagnostics market is projected to reach USD 2.2 billion by 2024 from USD 1.4 billon in 2019, at a CAGR of 8.4%. The growth of this market is driven by growing advancements in diagnostic devices, growth in the companion animal population, rising demand for pet insurance, growth in the number of veterinary practitioners in developed economies, and increasing disease control & disease prevention measures.

In this report, the global veterinary infectious disease diagnostics market has been segmented into technology, animal type, end-user, and region.  Based on technology, the veterinary infectious disease diagnostics market is segmented into immunodiagnostics, molecular diagnostics, and other veterinary diagnostic technologies. The immunodiagnostics segment is classified further into lateral flow assays, ELISA tests, and other immunodiagnostic products. The molecular diagnostics segment is divided further into PCR tests, microarrays, and other molecular diagnostics products.  

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=221816584



The immunodiagnostics segment is expected to register the highest growth rate in the veterinary infectious disease diagnostics market during the forecast period. The higher preference for advanced infectious disease diagnostic products by veterinarians, animal farm owners, government institutions & organizations, pet owners, and laboratory technicians; growing demand for early & accurate diagnosis; increasing preference for in-house testing; and the increasing applications of immunodiagnostics are supporting the growth of this application segment.

Based on animal type, veterinary infectious disease diagnostics market is segmented into companion animals and food-producing animals. The animal segment is sub-segmented into viral, bacterial, parasitic, and other infections. In 2018, the companion animals segment accounted for the larger share of the veterinary infectious disease diagnostics market. Increasing pet ownership (especially in developed countries), growing penetration of pet insurance, rising number of veterinary practitioners globally, and the increasing animal disease control and disease prevention measures will continue driving the growth of this segment.

Read more: https://www.marketsandmarkets.com/PressReleases/veterinary-infectious-disease-diagnostic.asp

Based on end-user, the veterinary infectious disease diagnostics market is segmented into reference laboratories, veterinary hospitals & clinics, research institutes & universities, and point-of-care/in-house testing. The reference laboratories segment was the largest end-user of the veterinary infectious disease diagnostics market in 2018. The large share of this end-user segment is mainly due to a large number of samples received for analysis in reference laboratories from small and large animal practices.

On the basis of region, the market is segmented into North America (US and Canada), Europe (Germany, UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa. North America accounted for the largest share of the veterinary infectious disease diagnostics market in 2018. Factors such as the increasing demand for prevention, early diagnosis & treatment of veterinary infectious disease diagnostics, growing pet insurance industry, rising veterinary healthcare expenditure, growing awareness of zoonotic diseases, and the growing number of veterinary practices are expected to drive the veterinary infectious disease diagnostics market in the region.